Skip to content
  • Sunday, 26 July 2026
  • 2:53 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Revolutionize Pediatric Diagnostics and National Access
Clinical Diagnostics & Pathology

Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Revolutionize Pediatric Diagnostics and National Access

Reynand Amr Wu May 9, 2026 0

Labcorp, a leading global life sciences company, and the Children’s Hospital of Philadelphia (CHOP), a globally recognized leader in pediatric…

Read More
Clinical Diagnostics & Pathology

Labcorp and Children’s Hospital of Philadelphia Forge Strategic Alliance to Advance Pediatric Diagnostics and National Access

Reynand Amr Wu Apr 25, 2026 0

Labcorp, a leading global life sciences company, and the Children’s Hospital of Philadelphia (CHOP), a preeminent pediatric research and clinical…

Read More
Pharmaceutical R&D

OZMOSI and Planview Forge Strategic Alliance to Revolutionize Pharmaceutical R&D Planning with AI-Powered Clinical Intelligence

Teuku Ryan Apr 24, 2026 0

OZMOSI and Planview have announced a significant partnership aimed at transforming how pharmaceutical organizations approach research and development (R&D) planning.…

Read More
Pharmaceutical R&D

Nucleai and Sirona Dx Forge Strategic Alliance to Revolutionize Spatial Proteomics for Drug Development

Teuku Ryan Apr 17, 2026 0

The pharmaceutical and biotechnology sectors are poised for a significant leap forward in drug development with the formation of a…

Read More
Pharmaceutical R&D

Regeneron Pharmaceuticals and Telix Pharmaceuticals Forge Strategic Alliance to Advance Precision Oncology Through Radiopharmaceutical Innovation

Teuku Ryan Apr 14, 2026 0

Regeneron Pharmaceuticals and Telix Pharmaceuticals have announced a significant partnership aimed at accelerating the development and commercialization of novel radiopharmaceutical…

Read More
Pharmaceutical R&D

Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors

Teuku Ryan Apr 11, 2026 0

Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…

Read More
Pharmaceutical R&D

Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies

Teuku Ryan Apr 11, 2026 0

Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies Roche, a global pharmaceutical giant,…

Read More
Pharmaceutical R&D

Biocytogen and Sihuan Pharmaceutical Forge Strategic Alliance to Accelerate Advanced Therapies, Including Novel Weight Loss Treatments

Teuku Ryan Apr 3, 2026 0

The pharmaceutical landscape is poised for significant advancement as Biocytogen, a leader in antibody-based drug discovery, and Sihuan Pharmaceutical, a…

Read More
Pharmaceutical R&D

Viz.ai and Alnylam Forge Strategic Alliance to Revolutionize Cardiac Amyloidosis Diagnosis and Care

Teuku Ryan Mar 26, 2026 0

In a significant development poised to reshape the landscape of cardiovascular medicine, Viz.ai has announced a groundbreaking collaboration with Alnylam…

Read More
Pharmaceutical R&D

Monash University and ClinChoice Forge Strategic Alliance to Accelerate Therapeutic Development and Enhance Patient Access to Novel Treatments

Teuku Ryan Mar 25, 2026 0

Australia’s Monash University, a leading research institution, and ClinChoice, a global contract research organization (CRO), have formally announced a significant…

Read More

Posts pagination

1 2
Collaborative Study Links Cellular Energy Disruption to Early-Stage Major Depressive Disorder in Young AdultsInvestigating the causes of rheumatoid arthritis painGenetic Mapping Reveals Explosive Growth of Chronic Myeloid Leukemia Years Before Clinical Diagnosis and Challenges Current Treatment ParadigmsIn Focus Wrapped: Metabolite monitoring in cell culture
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ